Extremity perfusion for sarcoma.
For more than 50 years, the technique of extremity perfusion has been explored in the limb salvage treatment of local, recurrent, and multifocal sarcomas. The "discovery" of tumor necrosis factor-alpha in combination with melphalan was a real breakthrough in the treatment of primarily irresectable extremity sarcomas. Development of new treatment strategies in extremity perfusion, better perfusion or infusion equipment, and modifying the technique and the use of molecular imaging technology might further improve limb salvage rates and decrease local failures in the future and provide more insight into the tumor biology of sarcoma.
Hoekstra
Harald Joan
HJ
Division of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. h.j.hoekstra@chir.umcg.nl
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects / Q000379:methods*; D005121:Extremities / Q000473:pathology*; D006801:Humans; D023821:Limb Salvage / Q000379:methods; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents